Omesti Bhd (XKLS:9008) Other Current Payables: RM26.94 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Omesti Bhd Other Current Payables?

Omesti Bhd XKLS:9008 +7.69% Other Current Payables is RM26.94 Mil as of Apr. 2026. The stock has 5 warning signs investors should review.

Omesti Bhd's Other Current Payables for the quarter that ended in Apr. 2026 was RM26.94 Mil.

Omesti Bhd's quarterly Other Current Payables increased from Sep. 2025 (RM0.00 Mil) to Jan. 2026 (RM27.49 Mil) but then declined from Jan. 2026 (RM27.49 Mil) to Apr. 2026 (RM26.94 Mil).

Omesti Bhd's annual Other Current Payables increased from Mar. 2022 (RM39.02 Mil) to Mar. 2023 (RM75.90 Mil) but then declined from Mar. 2023 (RM75.90 Mil) to Mar. 2024 (RM66.28 Mil).

Omesti Bhd Other Current Payables Related Terms

Omesti Bhd Other Current Payables Historical Data

* Premium members only.

The historical data trend for Omesti Bhd's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omesti Bhd Other Current Payables Chart

Omesti Bhd Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.83 48.30 39.02 75.90 66.28

Omesti Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Jan26 Apr26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.40 0.00 0.00 27.49 26.94

Omesti Bhd Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of RM26.94 Mil mean?
Omesti Bhd (XKLS:9008) has a Other Current Payables of RM26.94 Mil as of Apr. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Omesti Bhd and its competitors.
Is Omesti Bhd's Other Current Payables too high?
Omesti Bhd's current Other Current Payables is RM26.94 Mil.
How does Omesti Bhd's Other Current Payables compare to CTAS and CPRT?
Omesti Bhd's Other Current Payables of RM26.94 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Business Services company?
A good Other Current Payables depends on the Business Services industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Omesti Bhd and its competitors. Omesti Bhd's current Other Current Payables is RM26.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omesti Bhd stock overvalued right now?
Based on GuruFocus' analysis, Omesti Bhd (XKLS:9008) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.06, compared to a current price of RM0.07 — trading 16.7% above its estimated fair value. The current Other Current Payables is RM26.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Omesti Bhd (XKLS:9008), the current Other Current Payables is RM26.94 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omesti Bhd Business Description

Address No. 1 Persiaran Jalil 1, Bandar Bukit Jalil, 2-07-01 - Level 7, Plaza Bukit Jalil, Ho Hup Tower - Aurora Place, Kuala Lumpur, SGR, MYS, 57000
Omesti Bhd is focused on the delivery of technology solutions, systems integration services and the provision of recurring maintenance and managed services, predominantly for government and public sector customers. Its segments include Business Performance Services engages in provision of business performance improvement related services; Digital and Infrastructure Services engaged in the provision of a comprehensive range of tele/data communication, networking solutions and related services; and Healthcare Services engaged in the distribution of pharmaceutical products, vaccines and medical devices and provision of various medical services. The majority of the revenue is derived from Business Performance Services segment.